
Overview
Every day, my goal is to take the best surgical care of my patients' kidney or prostate cancer by offering the most up-to-date minimally invasive surgical treatments, while making sure that their experiences and outcomes at Duke Health are top-notch! As we look at the scans together and discuss biopsy results, it is important to me that I spend all of the time that my patients and their families need to clearly understand their diagnosis as well as all treatment options, so that we can make joint decisions about next steps and their treatment plan. Many of my patients are referred from all over the country to seek highly specialized urology care, including nonsurgical focal cryotherapy for prostate cancer, robotic surgery for prostate cancer, or robotic surgical removal of their kidney tumor called a partial nephrectomy, among other treatments, with our multidisciplinary, collaborative team. I always reassure and share my positive outlook with my patients as we navigate the health system together. My patients know that, as their physician, I will be their champion and advise them and guide them through their treatment. We are in this together.
Dr. Polascik is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy.
His clinical research consists of co-authoring 244 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pancreaticoduodenectomy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Polascik has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Davis Ambulatory Surgical Center
I am a surgical oncologist and researcher whose primary areas of focus are cancers of the liver and pancreas. As a surgeon, I believe in using minimally-invasive techniques, when possible, to speed up a patient’s recovery and get them to other avenues of care faster. My research is focused on clinical practice and clinical outcomes. I became interested in surgical oncology, because I enjoy the opportunity to restore hope to patients who may feel despair after their initial cancer diagnosis. I aim to restore hope by connecting with patients individually and providing them with options for treatment when they might feel they have none. I also work closely with my radiology oncology and medical oncology colleagues in crafting a treatment and care plan. Working together as a team often allows us to come up with a much better treatment plan than any of us could by ourselves. Dr. Zani is rated as a Distinguished provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.
Duke Cancer Center
I’m a fellowship-trained surgical oncologist who specializes in the surgical management of patients with gastrointestinal malignancies—including soft tissue sarcomas and pancreas, colorectal and gastric cancers. Many of my patients have advanced malignancies and I am always amazed at their resilience. Their determination to fight inspires me to aggressively pursue every surgical option and to study novel techniques to improve surgical outcomes. One of the most important reasons for patients to be treated at Duke is the emphasis on a team-oriented approach to every patient. Nearly every surgical cancer patient is discussed in a multidisciplinary tumor conference in order to assure state of the art care. When I am not in the hospital, my wife and I can be found chasing our two young children or running with our dog. Dr. Blazer is rated as a Distinguished provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Retroperitoneal Liposarcoma, Pancreaticoduodenectomy, and Pancreatectomy.
University Of North Carolina At Chapel Hill
Douglas Tyler is a General Surgeon and a Surgical Oncologist in Chapel Hill, North Carolina. Dr. Tyler is rated as a Distinguished provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Liposarcoma, Pancreaticoduodenectomy, and Cystectomy. Dr. Tyler is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Prostate CancerDr. Polascik isElite. Learn about Prostate Cancer.
- Distinguished
- Chromophobe Renal Cell CarcinomaDr. Polascik isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Polascik isDistinguished. Learn about Clear Cell Sarcoma.
- EmpyemaDr. Polascik isDistinguished. Learn about Empyema.
- Familial Prostate CancerDr. Polascik isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Polascik isDistinguished. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Polascik isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Advanced
- Bladder CancerDr. Polascik isAdvanced. Learn about Bladder Cancer.
- Enlarged Prostate (BPH)Dr. Polascik isAdvanced. Learn about Enlarged Prostate (BPH).
- Erectile Dysfunction (ED)Dr. Polascik isAdvanced. Learn about Erectile Dysfunction (ED).
- Intussusception in ChildrenDr. Polascik isAdvanced. Learn about Intussusception in Children.
- NephrectomyDr. Polascik isAdvanced. Learn about Nephrectomy.
- Non-Muscle Invasive Bladder CancerDr. Polascik isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Experienced
- Bilateral HydronephrosisDr. Polascik isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder Outlet ObstructionDr. Polascik isExperienced. Learn about Bladder Outlet Obstruction.
- Bladder ReconstructionDr. Polascik isExperienced. Learn about Bladder Reconstruction.
- Bladder StonesDr. Polascik isExperienced. Learn about Bladder Stones.
- Eunuchoidism Familial HypogonadotropicDr. Polascik isExperienced. Learn about Eunuchoidism Familial Hypogonadotropic.
- HydroceleDr. Polascik isExperienced. Learn about Hydrocele.



